Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

This study is testing a combination of two cancer drugs — venetoclax and azacitidine — as a new treatment for patients who have just been diagnosed with a type of blood cancer called T-cell acute lymphoblastic leukemia (T-ALL). **You may be eligible if...** - You are 15 years old or older - You have been newly diagnosed with T-ALL (a type of blood cancer affecting white blood cells) - You are reasonably well overall (able to manage most daily activities) - Your heart, lungs, liver, and kidneys are functioning adequately **You may NOT be eligible if...** - You are pregnant or breastfeeding, or not willing to use contraception - You have an uncontrolled active infection or active bleeding - You have had a stroke, blood clot, or brain bleed in the past year - You are allergic to the study drugs Talk to your doctor to see if this trial is right for you.